OncoSec Medical (ONCS) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free ONCS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineONCS - OncoSec Medical Incorporatedfinance.yahoo.com - June 24 at 8:41 AMWhy Is OncoSec Medical (ONCS) Stock Up 100% Today?markets.businessinsider.com - June 23 at 8:53 AMWhy John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionmsn.com - June 15 at 2:49 PMWhy Is OncoSec Medical (ONCS) Stock Down 48% Today?msn.com - June 15 at 9:48 AMmarketbeat.com - June 14 at 4:52 PMOncoSec Announces Closing of $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rulesfinance.yahoo.com - May 18 at 8:59 PMOncoSec Medical plunges 35% lower on sale of 1.4M shares of common stockmsn.com - May 16 at 4:15 PMOncoSec Announces $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rulesfinance.yahoo.com - May 16 at 4:15 PMOncoSec is encouraged after FDA meeting to discuss proposed neoadjuvant melanoma clinical programfinance.yahoo.com - May 16 at 9:56 AMOncoSec Receives $3.49 Million to Strengthen its Balance Sheet After Selling its Net Operating Loss Tax Benefits Through The New Jersey Economic Development Authority NOL Programfinance.yahoo.com - April 27 at 8:26 AMOncoSec Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rulesfinance.yahoo.com - April 11 at 5:48 PMWhy OncoSec Medical Shares Are Soaring Todaymsn.com - April 10 at 4:15 PMOncoSec Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rulesfinance.yahoo.com - April 10 at 4:15 PMmarketbeat.com - April 10 at 11:35 AMOncoSec Medical Inc (ONCS) is lower by 6.15% Tuesday In Premarket Tradingbenzinga.com - April 6 at 7:57 PMOncoSec Shares Disappointing Results From Skin Cancer Combo Therapy Trial, Sets Stage For Neoadjuvant Setting Studyfinance.yahoo.com - April 3 at 3:57 PMOncoSec crashes ~60% after TAVO-EP, Keytruda combo fails phase 2 skin cancer trialmsn.com - April 3 at 10:57 AMOncoSec Announces Clinical Data of the KEYNOTE-695 Trial Assessing TAVO™-EP in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Melanoma Refractory to anti-PD-1 Treatmentfinance.yahoo.com - April 3 at 10:57 AMOncoSec Medical Withdraws Planned Offering, Shares Rise Over 50%marketwatch.com - March 1 at 8:56 AMWhy is OncoSec Medical (ONCS) Stock Up 91% Today?msn.com - March 1 at 8:56 AMONCS.OQ - | Stock Price & Latest News | Reutersreuters.com - January 16 at 7:08 PMOncoSec Medical Stock (NASDAQ:ONCS), Quotes and News Summarybenzinga.com - January 5 at 3:51 PMPeering Into OncoSec Medical's Recent Short Interestmsn.com - December 8 at 5:34 PMOncoSec to Present at the RHK Capital Disruptive Growth Conference on December 6, 2022finance.yahoo.com - December 5 at 1:28 PMOncoSec Shares Drop 25% on Equity Offer Pricing After 51% Tuesday Surgemarketwatch.com - November 30 at 5:53 PMOncoSec Announces Pricing of $3.5 Million Public Offeringfinance.yahoo.com - November 30 at 12:53 PMOncoSec Touts Encouraging Early Data For Opdivo Combined Immunotherapy For Skin Cancerfinance.yahoo.com - November 24 at 8:52 AMOncoSec provides updates on cancer programs in new filingseekingalpha.com - November 23 at 4:19 PMLooking Into OncoSec Medical's Recent Short Interestmsn.com - November 22 at 5:01 PMmarketbeat.com - November 21 at 3:28 PMmarketbeat.com - November 21 at 12:20 PMOncoSec presents encouraging early data with TAVO™-EP combined with nivolumab (Opdivo®) in neoadjuvant melanomafinance.yahoo.com - November 15 at 9:33 PMOncoSec Announces Positive Clinical Data of the KEYNOTE-695 Trial Assessing TAVO-EP in Combination with Pembrolizumab (Keytruda®) in Patients with Advanced Melanoma Refractory to anti-PD-1 Treatmentfinance.yahoo.com - November 11 at 2:56 PMOncoSec Medical Shares Hit New Depths Ahead of Reverse Stock Split >ONCSmarketwatch.com - November 8 at 4:49 PMOncoSec Announces Reverse Stock Splitfinance.yahoo.com - November 8 at 4:49 PMOncoSec Cuts Workforce, Prioritizes Pipelinefinance.yahoo.com - October 13 at 4:36 AMOncoSec Medical to Restructure, Cut Jobsmarketwatch.com - October 4 at 10:56 PMOncoSec Medical To Reduce Staff By About 45%markets.businessinsider.com - October 4 at 10:56 PMOncoSec Announces Pipeline Prioritization and Workforce Reductionfinance.yahoo.com - October 4 at 5:55 PMRobert Arch joins OncoSec Medical as CEOseekingalpha.com - April 29 at 12:39 PMOncoSec Appoints Dr. Robert Arch as President and Chief Executive Officerfinance.yahoo.com - April 29 at 12:39 PMBTIG Maintains Buy on OncoSec Medical, Lowers Price Target to $5benzinga.com - March 16 at 11:40 AMOncoSec Medical (NASDAQ:ONCS) PT Lowered to $5.00marketbeat.com - March 16 at 7:39 AMOncoSec appoints new finance chiefseekingalpha.com - February 23 at 6:32 AMOncoSec Medical Inc Shares Approach 52-Week Low - Market Movernasdaq.com - October 9 at 3:12 AMOncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conferencefinance.yahoo.com - August 3 at 9:00 AMOncoSec Medical Incorporated Common Stock (ONCS)nasdaq.com - July 27 at 11:20 PM Get OncoSec Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCS and its competitors with MarketBeat's FREE daily newsletter. Email Address AI finds its first serious application (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry ONCS Media Mentions By Week ONCS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONCS News Sentiment▼0.000.34▲Average Medical News Sentiment ONCS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONCS Articles This Week▼01▲ONCS Articles Average Week Get OncoSec Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: 9 Meters Biopharma News Eiger BioPharmaceuticals News Comera Life Sciences News Sunshine Biopharma News SQZ Biotechnologies News GRI Bio News TC Biopharm News Panbela Therapeutics News Biodexa Pharmaceuticals News Histogen News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONCS) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoSec Medical Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.